Green formulation of copper nanoparticles by <i>Pistacia khinjuk</i> leaf aqueous extract: Introducing a novel chemotherapeutic drug for the treatment of prostate cancer-Reference-Cited by-同舟云学术

Green formulation of copper nanoparticles by Pistacia khinjuk leaf aqueous extract: Introducing a novel chemotherapeutic drug for the treatment of prostate cancer

Published:2024-01-01 Issue:1 Volume:22 Page:
ISSN:2391-5420
Container-title:Open Chemistry
language:en
Short-container-title:

Author:

Wang Zhuoqun¹,Li Ming²,Zhang Qi²,Xu Lei²

Affiliation:

1. Department of Medical Oncology, Zibo Central Hospital , No. 54, Gongqingtuan West Road, Zhangdian District , Zibo City , Shandong Province, Zibo, 255036 , China

2. Department of Urology, Zibo Central Hospital , No. 54 Gongqingtuan West Road, Zhangdian District , Zibo City , Shandong Province, Zibo, 255036 , China

Abstract

Abstract Prostate cancer is a cancer prevalent form characterized by serious clinical symptoms. The discovery of a novel supplement or medication for prostate cancer within the realm of chemotherapeutic drugs holds significant value. Our research involved the synthesis of copper nanoparticles (CuNPs) infused with Pistacia khinjuk leaf extract to explore their potential anti-prostate cancer, cytotoxic, and antioxidant properties. The green-formulated CuNPs were characterized by TEM, UV-Vis spectrophotometry, FE-SEM, FTIR. The FE-SEM and TEM findings prove the spherical structure with a size of 10–70 nm. The DPPH assay was carried out to examine the effectiveness of antioxidants. CuNPs exhibited the ability to inhibit 50% of DPPH at 215 µg/mL. To assess the anti-prostate cancer properties of CuNPs, an MTT assay was performed on NCI-H660, DU 145, LNCaP clone FGC, and LNCaP clone FGC-Luc2 cells. CuNPs exhibited remarkable efficacy in inhibiting prostate cancer growth, while demonstrating negligible toxicity towards normal cells. The LNCaP clone FGC cell line displayed the most potent anti-prostate cancer effects of CuNPs. IC50 of CuNPs was 322, 365, 247, and 273 on NCI-H660, DU 145, LNCaP clone FGC, and LNCaP clone FGC-Luc2 prostate cancer cells. CuNPs containing Pistacia khinjuk were found to possess noteworthy anti-prostate carcinoma characteristics and presented excellent antioxidant potentials, as highlighted by this study.

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/chem-2024-0034/pdf

Reference45 articles.

1. Wicki A, Hagmann J. Diet and cancer. Swiss Med Wkly. 2011;141:w13250.

2. Van Lier EA, van Kranen HJ, Van Vliet JA, Rahamat-Langendoen JC. Estimated number of new cancer cases attributable to infection in the Netherlands in 2003. Cancer Lett. 2008;272(2):226–31.

3. Reece JB, Urry LA, Cain ML, Wasserman SA, Minorsky PV, Campbell NA. Campbell biology. 9th edn. San Francisco, California, USA: Benjamin Cummings; 2012. p. 1464.

4. Bansal P, Gupta V, Bansal R, Sapra R. Dietary phytochemicals in cell cycle arrest and apoptosis- an insight. J Drug Deliv Ther. 2012;2(2):8–18.

5. Kosha A, Farahbakhsh M, Hakimi S, Abdollahi L, Golzari M, Seif M. Epidemiology of cancer in west Azarbaijan in 2007. Med J Tabriz Univ Med Sci. 2010;32(4):74–9. [Farsi].